Home
About
Services
Partners
Client Portfolio
News
Contact
Asian shares resume decline, Saudi tensions lift oil prices
October 15, 2018
Sears, once a retail titan, files for Chapter 11 bankruptcy
October 15, 2018
0
Novo Nordisk picks AstraZeneca executive to head biopharma business
Published by
Muller&Green
at
October 15, 2018
Categories
RSS
Tags
Novo Nordisk has hired AstraZeneca’s head of cardiovascular and metabolic diseases to head its biopharma business, which has been struggling with declining sales and a failed acquisition.
Powered by
WPeMatico
Muller&Green
Related posts
June 18, 2020
Chanel warns virus impact will linger on luxury sector
Read more
June 18, 2020
IMF says deeper-than-expected contraction in U.S. economy likely in second quarter
Read more
June 18, 2020
Prudential sells Jackson equity stake to Apollo-backed Athene for $500 million
Read more